Showing results (1-10 of 772) with videos related to
Sort By:
Pageof 78
Journal of Clinical Neurology (Seoul, Korea)|November 17, 2011
New insights into neuromyelitis opticaWoojun Kim, Su-Hyun Kim, Ho Jin KimMultiple Sclerosis International|December 22, 2012
Brain abnormalities in neuromyelitis optica spectrum disorderWoojun Kim, Su-Hyun Kim, So-Young Huh, et al.Journal of Clinical Neurology (Seoul, Korea)|January 29, 2015
Oral disease-modifying therapies for multiple sclerosisWoojun Kim, Manuella Edler Zandoná, Su-Hyun Kim, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 23, 2012
Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?Su-Hyun Kim, Woojun Kim, Xue Feng Li, et al.Archives of Neurology|July 13, 2011
Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 yearsSu-Hyun Kim, Woojun Kim, Xue Feng Li, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2011
Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorderWoojun Kim, Su-Hyun Kim, Sang Hyun Lee, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 5, 2012
Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormalitySu-Hyun Kim, Woojun Kim, Myeong-Cherl Kook, et al.Journal of Clinical Neurology (Seoul, Korea)|July 14, 2020
Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum DisorderWoojun Kim, Ho Jin KimExpert Review of Clinical Immunology|November 22, 2022
An update on biologic treatments for neuromyelitis optica spectrum disorderWoojun Kim, Ho Jin KimArchives of Neurology|December 15, 2010
Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis opticaSu-Hyun Kim, Woojun Kim, Min Su Park, et al.Pageof 78